IDXX · 8-K · 20260804PR090033

Market Demand Trends

IDEXX LABORATORIES INC /DE · 2026-08-04 · Importance 54 · Surprise 40

CAG Diagnostics recurring revenue grew 11% reported and 10% organically, with 12% organic growth internationally and 10% in the U.S. Growth was volume-driven and supported by customer expansion, IDEXX innovations, and increased diagnostic utilization. IDEXX VetLab consumables increased 15% reported and 14% organically, driven by testing utilization, recent product launches, net new customers, an 11% expansion in the global premium instrument installed base, and net price gains. Reference laboratory diagnostic and consulting services grew 11% reported and 10% organically on higher testing volumes and net new customer gains.